conivaptan has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Arai, Y; Tahara, A; Tomura, Y; Tsukada, J; Wada, K; Yatsu, T | 1 |
| Arai, Y; Fujimori, A; Matsukawa, U; Miyata, K; Sasamata, M; Sudoh, K; Wada, K; Yatsu, T | 1 |
2 other study(ies) available for conivaptan and Cardiovascular Stroke
| Article | Year |
|---|---|
Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Wistar; Vasopressins | 2002 |
Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Injections, Intravenous; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley | 2005 |